Voyager Therapeutics, Inc. (VYGR) Stock Forecast
Data as of May 2, 2026Healthcare · Current price $3.75 (+0.67%)
Price Target Range
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
| Date | Analyst | Firm | Price Target | Upside |
|---|---|---|---|---|
| Mar 12, 2025 | Yanan Zhu | Wells Fargo | $10.00 | +166.3% |
| Nov 13, 2024 | Jay Olson | Oppenheimer | $18.00 | +379.4% |
| Sep 25, 2024 | Jack Allen | Robert W. Baird | $18.00 | +379.4% |
| May 14, 2024 | Laura Chico | Wedbush | $8.00 | +113.0% |
| Jan 2, 2024 | Jim Birchenough | Wells Fargo | $14.00 | +272.8% |
| May 10, 2023 | Joon Lee | Truist Financial | $18.00 | +379.4% |
Top Analysts Covering VYGR
VYGR vs Sector & Market
| Metric | VYGR | Healthcare Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 2.00 | 2.24 | 2.41 |
| Analyst Count | 2 | 8 | 18 |
| Target Upside | +283.5% | +1149.9% | +14.9% |
| P/E Ratio | -1.85 | 6.87 | 31.19 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-06-30 | $4M | $10M | $19M | 7 |
| 2026-09-30 | $5M | $15M | $32M | 4 |
| 2026-12-31 | $4M | $14M | $31M | 4 |
| 2027-03-31 | $3M | $9M | $19M | 4 |
| 2027-06-30 | $3M | $9M | $19M | 3 |
| 2027-09-30 | $3M | $9M | $19M | 3 |
| 2027-12-31 | $3M | $9M | $20M | 3 |
| 2028-12-31 | $75M | $75M | $75M | 8 |
| 2029-12-31 | $46M | $96M | $171M | 7 |
| 2030-12-31 | $45M | $95M | $168M | 7 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-06-30 | $-0.61 | $-0.51 | $-0.26 | 7 |
| 2026-09-30 | $-1.17 | $-0.45 | $-0.05 | 3 |
| 2026-12-31 | $-1.06 | $-0.41 | $-0.04 | 3 |
| 2027-03-31 | $-1.17 | $-0.45 | $-0.05 | 3 |
| 2027-06-30 | $-1.19 | $-0.46 | $-0.05 | 2 |
| 2027-09-30 | $-1.20 | $-0.47 | $-0.05 | 2 |
| 2027-12-31 | $-1.21 | $-0.47 | $-0.05 | 2 |
| 2028-12-31 | $-3.05 | $-1.60 | $0.06 | 7 |
| 2029-12-31 | $-2.79 | $-1.40 | $-0.44 | 2 |
| 2030-12-31 | $-2.48 | $-1.24 | $-0.39 | 5 |
Frequently Asked Questions
What is the analyst consensus for VYGR?
The consensus among 2 analysts covering Voyager Therapeutics, Inc. (VYGR) is Buy with an average price target of $14.40.
What is the highest price target for VYGR?
The highest price target for VYGR is $18.00, set by Jay Olson at Oppenheimer on 2024-11-13.
What is the lowest price target for VYGR?
The lowest price target for VYGR is $8.00, set by Laura Chico at Wedbush on 2024-05-14.
How many analysts cover VYGR?
2 analysts have issued ratings for Voyager Therapeutics, Inc. in the past 12 months.
Is VYGR a buy or sell right now?
Based on 2 analyst ratings, VYGR has a consensus rating of Buy (2.00/5) with a +283.5% upside to the consensus target of $14.40.
What are the earnings estimates for VYGR?
Analysts estimate VYGR will report EPS of $-0.51 for the period ending 2026-06-30, with revenue estimated at $10M.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.